Your browser doesn't support javascript.
loading
Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
Johns, Matthew C; Eick, Angelia A; Blazes, David L; Lee, Seung-eun; Perdue, Christopher L; Lipnick, Robert; Vest, Kelly G; Russell, Kevin L; DeFraites, Robert F; Sanchez, Jose L.
Afiliación
  • Johns MC; Division of GEIS Operations, Armed Forces Health Surveillance Center, Silver Spring, Maryland, United States of America. matthew.c.johns@us.army.mil
PLoS One ; 5(5): e10722, 2010 May 19.
Article en En | MEDLINE | ID: mdl-20502705
ABSTRACT

INTRODUCTION:

A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. MATERIALS AND

METHODS:

Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%).

CONCLUSION:

A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estaciones del Año / Vacunas contra la Influenza / Brotes de Enfermedades / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Personal Militar Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estaciones del Año / Vacunas contra la Influenza / Brotes de Enfermedades / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Personal Militar Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos